R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Journal of comparative neurology

• Publication date

  2007-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cne.21515PMID 17948889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.

  2007influential reference
• Wild-type huntingtin plays a role in brain development and neuronal survival

  2007influential reference
• Total number of neurons in the habenular nuclei of the rat epithalamus: a stereological study

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

  2005influential reference
• Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice

  2005influential reference
• Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.

  2005influential reference
• Regional cortical thinning in preclinical Huntington disease and its relationship to cognition

  2005cited by this paper
• Polyglutamine expansion of huntingtin impairs its nuclear export

  2005cited by this paper
• Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice.

  2005cited by this paper
• Normal huntingtin function: an alternative approach to Huntington's disease

  2005influential reference
• Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.

  2005cited by this paper
• Huntingtin Bodies Sequester Vesicle-Associated Proteins by a Polyproline-Dependent Interaction

  2004cited by this paper
• Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro

  2004influential reference
• Dendritic spine pathology and deficits in experience‐dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice

  2004influential reference
• Distribution of methionine and leucine enkephalin neurons within the social behavior circuitry of the male Syrian hamster brain.

  2004cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004influential reference
• Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis

  2004cited by this paper
• Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor

  2004cited by this paper
• Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.

  2004cited by this paper
• Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

  2004cited by this paper
• Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.

  2004influential reference
• Evidence for more widespread cerebral pathology in early HD

  2003cited by this paper
• Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders

  2003cited by this paper
• Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.

  2003influential reference
• Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease

  2003cited by this paper
• Standardization and statistical approaches to therapeutic trials in the R6/2 mouse.

  2003cited by this paper
• Huntington's disease: a synaptopathy?

  2003cited by this paper
• Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease

  2003influential reference
• Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.

  2002cited by this paper
• Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation

  2002cited by this paper
• Regional and progressive thinning of the cortical ribbon in Huntington’s disease

  2002cited by this paper
• Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

  2002cited by this paper
• Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses.

  2002cited by this paper
• Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease.

  2002influential reference
• Quantitative Structural Changes in the Ageing Brain

  2002cited by this paper
• Early Motor Dysfunction and Striosomal Distribution of Huntingtin Microaggregates in Huntington's Disease Knock-In Mice

  2002influential reference
• Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice

  2002influential reference
• NMDA receptor function in mouse models of Huntington disease

  2001cited by this paper
• Neurological abnormalities in a knock-in mouse model of Huntington's disease.

  2001influential reference
• Neuralized functions as an E3 ubiquitin ligase during Drosophila development.

  2001cited by this paper
• Neurons Lacking Huntingtin Differentially Colonize Brain and Survive in Chimeric Mice

  2001cited by this paper
• Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

  2001influential reference
• Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease

  2001influential reference
• Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production.

  2001influential reference
• Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

  2000influential reference
• Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation

  2000cited by this paper
• Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.

  2000cited by this paper
• The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.

  2000influential reference
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000influential reference
• Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.

  2000influential reference
• Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.

  2000influential reference
• Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.

  2000influential reference
• Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease

  2000cited by this paper
• Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

  2000influential reference
• Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3

  2000cited by this paper
• Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

  1999influential reference
• Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

  1999influential reference
• Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

  1999cited by this paper
• Huntingtin aggregates may not predict neuronal death in Huntington's disease

  1999influential reference
• Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

  1999influential reference
• Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

  1999cited by this paper
• Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.

  1999cited by this paper
• In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.

  1999cited by this paper
• Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.

  1999influential reference
• A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

  1999cited by this paper
• Caspase-8 is required for cell death induced by expanded polyglutamine repeats.

  1999cited by this paper
• Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington’s Disease

  1999influential reference
• Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation

  1999cited by this paper
• Huntington aggregates may not predict neuronal death in Huntington's disease.

  1999cited by this paper
• Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.

  1999cited by this paper
• A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections.

  1999cited by this paper
• Are there multiple pathways in the pathogenesis of Huntington's disease?

  1999cited by this paper
• Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.

  1999influential reference
• Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase Inhibition

  1999cited by this paper
• Neuronal intranuclear inclusions in polyglutamine diseases: nuclear weapons or nuclear fallout?

  1998cited by this paper
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998influential reference
• Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract*

  1998influential reference
• Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA

  1998influential reference
• The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity

  1998cited by this paper
• Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

  1998influential reference
• Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

  1998influential reference
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998influential reference
• Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.

  1998cited by this paper
• Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

  1998cited by this paper
• Huntingtin interacts with a family of WW domain proteins.

  1998cited by this paper
• Neuronal intranuclear inclusions in polyglutamine diseases : nuclear weapons or nuclear fallout?

  1998cited by this paper
• Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.

  1998cited by this paper
• Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways.

  1998cited by this paper
• The fatal attraction of polyglutamine‐containing proteins

  1998cited by this paper
• Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.

  1998cited by this paper
• Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum.

  1998cited by this paper
• Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

  1997cited by this paper
• Restrictive clonal allocation in the chimeric mouse brain.

  1997cited by this paper
• Huntingtin localization in brains of normal and Huntington's disease patients

  1997cited by this paper
• Basal forebrain neuronal loss in mice lacking neurotrophin receptor p75.

  1997cited by this paper
• Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.

  1997cited by this paper
• Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion

  1997cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997influential reference

• Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation

  2025cites this paper
• Localization of mutant huntingtin with HTT Exon1 P90 C-terminal neoepitope antibodies in relation to regional and neuronal vulnerability in forebrain in Q175 mice and human huntington's disease

  2025influential citation
• Neuroinflammatory Proteins in Huntington’s Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications

  2024cites this paper
• Neurochemistry and circuit organization of the lateral spiriform nucleus of birds: A uniquely nonmammalian direct pathway component of the basal ganglia

  2024cites this paper
• Enhanced Hippocampal Spare Capacity in Q175DN Mice Despite Elevated mHTT Aggregation

  2024cites this paper
• Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics

  2022cites this paper
• Aggregation chimeras provide evidence of in vivo intercellular correction in ovine CLN6 neuronal ceroid lipofuscinosis (Batten disease)

  2021cites this paper
• Precise CAG repeat contraction in a Huntington’s Disease mouse model is enabled by gene editing with SpCas9-NG

  2021cites this paper
• A yeast model of the ALS protein Matrin3 uncovers Hsp90 and its co-chaperone Sti1 as modifiers of misfolding and toxicity

  2021cites this paper
• Progression of basal ganglia pathology in heterozygous Q175 knock‐in Huntington's disease mice

  2020cites this paper
• Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism

  2020cites this paper
• Effect of early embryonic deletion of huntingtin from pyramidal neurons on the development and long-term survival of neurons in cerebral cortex and striatum

  2017influential citation
• Regulación de canales Kv4 por subunidades beta accesorias

  2017cites this paper
• A Novel Closed-Head Model of Mild Traumatic Brain Injury Using Focal Primary Overpressure Blast to the Cranium in Mice

  2016cites this paper
• Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression

  2015cites this paper
• The Neuropathology of Huntington's Disease.

  2015cites this paper
• Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189

  2014cites this paper
• A Novel Closed-Head Model of Mild Traumatic Brain Injury Caused by Primary Overpressure Blast to the Cranium Produces Sustained Emotional Deficits in Mice

  2014cites this paper
• Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

  2014cites this paper
• Development of tools in mouse for future gene therapy : promoters for the CNS, and novel expression models of neural stem cell regulator, NR2E1.

  2013cites this paper
• Aggregation formation in the polyglutamine diseases: Protection at a cost?

  2013cites this paper
• Surveying the Landscape of Huntington's Disease Mechanisms, Measurements, and Medicines

  2013cites this paper
• Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

  2013cites this paper
• The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.

  2012influential citation
• New Perspectives on the Neuropathology in Huntington's Disease in the Human Brain and its Relation to Symptom Variation

  2012cites this paper
• Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice.

  2012cites this paper
• Light and electron microscopic characterization of the evolution of cellular pathology in the R6/1 Huntington's disease transgenic mice.

  2012cites this paper
• Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh(CAG)150 Huntington's disease knock-in mouse.

  2012cites this paper
• Light and electron microscopic characterization of the evolution of cellular pathology in HdhQ92 Huntington's disease knock-in mice.

  2012cites this paper
• Huntington's Disease: Can Mice Lead the Way to Treatment?

  2011cites this paper
• Experimental Sey mouse chimeras reveal the developmental deficiencies of Pax6-null granule cells in the postnatal cerebellum.

  2011cites this paper
• Genetic mouse models of Huntington’s disease: focus on electrophysiological mechanisms

  2010cites this paper
• Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

  2010cites this paper
• BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease

  2010cites this paper
• Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.

  2010influential citation
• Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity

  2009cites this paper
• Calcium channel dysfunction in Huntington's disease

  2009cites this paper
• CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse.

  2009cites this paper
• Reconstituting a Human Brain in Animals: A Jewish Perspective on Human Sanctity

  2008cites this paper
• Loike and TendLer • a Jewish PersPecTive on human sancTiTy

  2008cites this paper